Marksans Pharma Q1 Results

  • BSE: 524404
  • NSE: MARKSANS
  • ISIN: INE750C01026
  • Sector: Biotechnology & Drugs
BSE
315.77.15 (2.32%)
Volume83.85 K
Updated: Mon 25 Nov, 2024 | 15:40:44
NSE
315.556.90 (2.24%)
Volume1.48 M
Updated: Mon 25 Nov, 2024 | 15:44:08
Today: 310.00
318.70
52-Wk: 126.05
328.35

Q1 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Marksans Pharma Q1 Results

    *All figures in crores except per share values
    Fiscal PeriodJun 24Mar 23QoQ CompJun 23YoY Comp
    Total Revenue 590.62485.98-%500.03-%
    Selling/ General/ Admin Expenses Total 80.4860.89-%68.24-%
    Depreciation/ Amortization 20.4413.94-%13.66-%
    Other Operating Expenses Total 119.9271.70-%87.07-%
    Total Operating Expense 482.63390.37-%411.73-%
    Operating Income 107.9995.60-%88.31-%
    Net Income Before Taxes 120.02104.17-%96.83-%
    Net Income 88.7581.93-%68.66-%
    Diluted Normalized EPS 1.961.85-%1.52-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts